Doctor Care (ASX:DOC) share price slides 11% after quarterly results

The telehealth provider has had an off-colour morning on the ASX.

| More on:
a doctor with stethoscope around neck sits as a computer with head in hand, looking despondent.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Doctor Care Anywhere Group Plc (ASX: DOC) share price has slipped into the red in early trading on Wednesday. Today's dip comes as the company released its quarterly results this morning.

Let's examine Doctor Care's results in a bit finer detail.

But first – a bit more on Doctor Care

Doctor Care has expertise in providing digital healthcare and telehealth services to patients.

It has a network of insurers, healthcare providers and corporate customers designed to connect with patients.

The company has a market capitalisation of $279 million at the time of writing.

Doctor Care's quarterly results

The company recorded unaudited revenue of $8.9 million this quarter, a 78% year-on-year increase.

It also delivered 89,400 consultations across the quarter, a healthy expansion of 69% from the year prior.

Doctor Care's "recruitment drive" also added 71 new GPs to its platform, with a further 100 in the pipeline.

As a result of these additions, the company hopes to provide "up to 45,000 appointment capacity" per month by the end of Q3.

Diagnostic referral volumes were also up 34% from the previous quarter and broad strengths were underlined by "continued demand as the UK economy unlocks".

While people entitled to use the company's services remained flat from the previous quarter at 2.4 million, its "activated lives" — or people signing up for the service — grew 12.7% quarter-on-quarter and 90% from the year prior.

Additional takeouts

With respect to guidance, Doctor Care reinstated its FY21 estimates of "revenue growth of at least 100% above FY 2020".

For reference, Doctor Care recognised revenue of $11.6 million for the FY 2020 and made a loss of $31.3 million.

Commenting on the performance this quarter, Doctor Care CEO Dr Bayju Thakar stated:

Our outlook for 2021 remains positive following a robust performance in a quarter during which patient demand has continued to grow rapidly… Nevertheless, this has been a quarter of significant challenges as a result of the demand on GPs to deliver the national vaccination programme.

The company's chair Jonathan Baines added:

The UK primary health care system will continue to remain under extreme pressure, contributing to significantly increased demand for our service as demonstrated by the growth in activated lives and record number of daily consultations this quarter. We remain confident in our guidance for year on year revenue growth of at least 100% above FY 2020.

However, investors seem to view the results unfavourably and are selling Doctor Care shares in droves this morning.

After earlier trading down ~11% on their opening price, Doctor Care shares are now changing hands for 80 cents, an 8.5% drop at the time of writing.

Doctor Care share price snapshot

The Doctor Care share price has posted a year to date loss of almost 34%, extending the previous 12 months' loss of close to 15%.

These returns have lagged the S&P/ASX 200 Index (ASX: XJO)'s return of ~23% over the previous year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A young well-dressed couple at a luxury resort celebrate successful life choices.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors kept up the selling this session.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Morgans says these ASX 200 shares can rise 20%+

The broker says these shares could offer major upside.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Broker Notes

Brokers rate 2 ASX All Ords rippers of 2025: Is their phenomenal run over?

Both of these ASX shares more than tripled in value last year.

Read more »

a woman puts her hand to her chin and looks to the side deep in thought as though pondering something significant.
Broker Notes

2 ASX 200 gold shares to buy and 1 to sell: experts

After exceptional share price growth for 2 years, experts say investors need to choose their gold stocks carefully.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why 4DMedical, ARB, Inghams, and Qoria shares are tumbling today

These shares are under pressure on Tuesday. What's going on?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Market News

Why Bellevue Gold, DroneShield, Hub24, and Telix shares are storming higher today

These shares are rising on Tuesday despite the market weakness.

Read more »

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.
Resources Shares

ASX 200 materials was the best sector of 2025 but it's time to sell these 3 shares: broker

Morgan Stanley has just updated its ratings and 12-month price targets on 3 ASX 200 mining shares.

Read more »

A red heart-shaped balloon float up above the plain white ones, indicating the best shares
Dividend Investing

Why this could be the best ASX dividend stock to buy today

There are few ideas that match this option for dividend investors.

Read more »